APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Type 2 Diabetes Mellitus Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Type 2 Diabetes Mellitus Treatment Industry Growth and Trends Forecast to 2032

Report ID 174043970127 December 202587 pages

Choose your research edition.

Industry ResearchType 2 Diabetes Mellitus Treatment Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 2 Diabetes Mellitus Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Type 2 Diabetes Mellitus Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 2 Diabetes Mellitus Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 2 Diabetes Mellitus Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Type 2 Diabetes Mellitus Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Type 2 Diabetes Mellitus Treatment market include Takeda Pharmaceutical Co. Ltd, Sanofi SA, Novartis AG, Novo Nordisk AS, Merck & Co. Inc, Eli Lilly and Co., Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH and AstraZeneca PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Type 2 Diabetes Mellitus Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Type 2 Diabetes Mellitus Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Type 2 Diabetes Mellitus Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Type 2 Diabetes Mellitus Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Type 2 Diabetes Mellitus Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Type 2 Diabetes Mellitus Treatment Market by Company

Takeda Pharmaceutical Co. Ltd

Sanofi SA

Novartis AG

Novo Nordisk AS

Merck & Co. Inc

Eli Lilly and Co.

Daiichi Sankyo Co. Ltd

Boehringer Ingelheim International GmbH

AstraZeneca PLC

Type 2 Diabetes Mellitus Treatment Segment by Type

Insulin

SGLT2 Inhibitors

GLP-1 Receptor Agonists

DPP-4 Inhibitors

Others

Type 2 Diabetes Mellitus Treatment Segment by Application

Hospitals

Clinics

Other

Type 2 Diabetes Mellitus Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes Mellitus Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes Mellitus Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes Mellitus Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Type 2 Diabetes Mellitus Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Type 2 Diabetes Mellitus Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2021-2026) Table 4. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2027-2032) Table 6. Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Type 2 Diabetes Mellitus Treatment Market Size Share by Type (2021-2026) Table 9. Global Type 2 Diabetes Mellitus Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Type 2 Diabetes Mellitus Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Type 2 Diabetes Mellitus Treatment Market Size Share by Application (2021-2026) Table 24. Global Type 2 Diabetes Mellitus Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Type 2 Diabetes Mellitus Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Type 2 Diabetes Mellitus Treatment Industry Trends Table 37. Type 2 Diabetes Mellitus Treatment Industry Drivers Table 38. Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges Table 39. Type 2 Diabetes Mellitus Treatment Industry Restraints Table 40. Global Type 2 Diabetes Mellitus Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Type 2 Diabetes Mellitus Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Type 2 Diabetes Mellitus Treatment Key Company Headquarters & Area Served Table 44. Global Type 2 Diabetes Mellitus Treatment Company, Product Type & Application Table 45. Global Type 2 Diabetes Mellitus Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Type 2 Diabetes Mellitus Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Pharmaceutical Co. Ltd Company Information Table 49. Takeda Pharmaceutical Co. Ltd Business Overview Table 50. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 52. Takeda Pharmaceutical Co. Ltd Recent Development Table 53. Sanofi SA Company Information Table 54. Sanofi SA Business Overview Table 55. Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio Table 57. Sanofi SA Recent Development Table 58. Novartis AG Company Information Table 59. Novartis AG Business Overview Table 60. Novartis AG Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio Table 62. Novartis AG Recent Development Table 63. Novo Nordisk AS Company Information Table 64. Novo Nordisk AS Business Overview Table 65. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio Table 67. Novo Nordisk AS Recent Development Table 68. Merck & Co. Inc Company Information Table 69. Merck & Co. Inc Business Overview Table 70. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio Table 72. Merck & Co. Inc Recent Development Table 73. Eli Lilly and Co. Company Information Table 74. Eli Lilly and Co. Business Overview Table 75. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio Table 77. Eli Lilly and Co. Recent Development Table 78. Daiichi Sankyo Co. Ltd Company Information Table 79. Daiichi Sankyo Co. Ltd Business Overview Table 80. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 82. Daiichi Sankyo Co. Ltd Recent Development Table 83. Boehringer Ingelheim International GmbH Company Information Table 84. Boehringer Ingelheim International GmbH Business Overview Table 85. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio Table 87. Boehringer Ingelheim International GmbH Recent Development Table 88. AstraZeneca PLC Company Information Table 89. AstraZeneca PLC Business Overview Table 90. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio Table 92. AstraZeneca PLC Recent Development Table 93. North America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2026) Table 96. North America Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Type 2 Diabetes Mellitus Treatment Market Share Forecast by Country (2027-2032) Table 98. Europe Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2026) Table 101. Europe Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Type 2 Diabetes Mellitus Treatment Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2026) Table 106. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Share Forecast by Country (2027-2032) Table 108. Latin America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Latin America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Latin America Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2026) Table 111. Latin America Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Latin America Type 2 Diabetes Mellitus Treatment Market Share Forecast by Country (2027-2032) Table 113. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2026) Table 116. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share Forecast by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Type 2 Diabetes Mellitus Treatment Product Image Figure 3. Global Type 2 Diabetes Mellitus Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Type 2 Diabetes Mellitus Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2021-2032) Figure 7. North America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Insulin Image Figure 13. Global Insulin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. SGLT2 Inhibitors Image Figure 15. Global SGLT2 Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. GLP-1 Receptor Agonists Image Figure 17. Global GLP-1 Receptor Agonists Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. DPP-4 Inhibitors Image Figure 19. Global DPP-4 Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Type 2 Diabetes Mellitus Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Type 2 Diabetes Mellitus Treatment Market Share by Type 2025 VS 2032 Figure 24. North America Type 2 Diabetes Mellitus Treatment Market Size Share by Type (2021-2032) Figure 25. Europe Type 2 Diabetes Mellitus Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America Type 2 Diabetes Mellitus Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Share by Type (2021-2032) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinics Image Figure 32. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Type 2 Diabetes Mellitus Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Type 2 Diabetes Mellitus Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Type 2 Diabetes Mellitus Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Type 2 Diabetes Mellitus Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Type 2 Diabetes Mellitus Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Type 2 Diabetes Mellitus Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Type 2 Diabetes Mellitus Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Type 2 Diabetes Mellitus Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 47. Europe Type 2 Diabetes Mellitus Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Type 2 Diabetes Mellitus Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 53. Latin America Type 2 Diabetes Mellitus Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Type 2 Diabetes Mellitus Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • SGLT2 Inhibitors
  • GLP-1 Receptor Agonists
  • DPP-4 Inhibitors
  • Others
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Co. Ltd
  • Sanofi SA
  • Novartis AG
  • Novo Nordisk AS
  • Merck & Co. Inc
  • Eli Lilly and Co.
  • Daiichi Sankyo Co. Ltd
  • Boehringer Ingelheim International GmbH
  • AstraZeneca PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Type 2 Diabetes Mellitus Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
  8. 1.5.1 North America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (2021-2032)
2 Type 2 Diabetes Mellitus Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Insulin
  3. 2.1.2 SGLT2 Inhibitors
  4. 2.1.3 GLP-1 Receptor Agonists
  5. 2.1.4 DPP-4 Inhibitors
  6. 2.1.5 Others
  7. 2.2 Global Type 2 Diabetes Mellitus Treatment Market Size by Type
  8. 2.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Type 2 Diabetes Mellitus Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Type 2 Diabetes Mellitus Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Type 2 Diabetes Mellitus Treatment Market Size by Regions
  12. 2.3.1 North America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Type (2021-2026)
3 Type 2 Diabetes Mellitus Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Clinics
  4. 3.1.3 Other
  5. 3.2 Global Type 2 Diabetes Mellitus Treatment Market Size by Application
  6. 3.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Type 2 Diabetes Mellitus Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Type 2 Diabetes Mellitus Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Type 2 Diabetes Mellitus Treatment Market Size by Regions
  10. 3.3.1 North America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Type 2 Diabetes Mellitus Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Type 2 Diabetes Mellitus Treatment Industry Trends
  2. 4.2 Type 2 Diabetes Mellitus Treatment Industry Drivers
  3. 4.3 Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges
  4. 4.4 Type 2 Diabetes Mellitus Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Type 2 Diabetes Mellitus Treatment Revenue (2021-2026)
  2. 5.2 Global Type 2 Diabetes Mellitus Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Type 2 Diabetes Mellitus Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Type 2 Diabetes Mellitus Treatment Company, Product Type & Application
  5. 5.5 Global Type 2 Diabetes Mellitus Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Type 2 Diabetes Mellitus Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Type 2 Diabetes Mellitus Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Type 2 Diabetes Mellitus Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Co. Ltd
  2. 6.1.1 Takeda Pharmaceutical Co. Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Co. Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Co. Ltd Recent Developments
  7. 6.2 Sanofi SA
  8. 6.2.1 Sanofi SA Company Information
  9. 6.2.2 Sanofi SA Business Overview
  10. 6.2.3 Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio
  12. 6.2.5 Sanofi SA Recent Developments
  13. 6.3 Novartis AG
  14. 6.3.1 Novartis AG Company Information
  15. 6.3.2 Novartis AG Business Overview
  16. 6.3.3 Novartis AG Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio
  18. 6.3.5 Novartis AG Recent Developments
  19. 6.4 Novo Nordisk AS
  20. 6.4.1 Novo Nordisk AS Company Information
  21. 6.4.2 Novo Nordisk AS Business Overview
  22. 6.4.3 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio
  24. 6.4.5 Novo Nordisk AS Recent Developments
  25. 6.5 Merck & Co. Inc
  26. 6.5.1 Merck & Co. Inc Company Information
  27. 6.5.2 Merck & Co. Inc Business Overview
  28. 6.5.3 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio
  30. 6.5.5 Merck & Co. Inc Recent Developments
  31. 6.6 Eli Lilly and Co.
  32. 6.6.1 Eli Lilly and Co. Company Information
  33. 6.6.2 Eli Lilly and Co. Business Overview
  34. 6.6.3 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio
  36. 6.6.5 Eli Lilly and Co. Recent Developments
  37. 6.7 Daiichi Sankyo Co. Ltd
  38. 6.7.1 Daiichi Sankyo Co. Ltd Company Information
  39. 6.7.2 Daiichi Sankyo Co. Ltd Business Overview
  40. 6.7.3 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  42. 6.7.5 Daiichi Sankyo Co. Ltd Recent Developments
  43. 6.8 Boehringer Ingelheim International GmbH
  44. 6.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 6.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 6.8.3 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio
  48. 6.8.5 Boehringer Ingelheim International GmbH Recent Developments
  49. 6.9 AstraZeneca PLC
  50. 6.9.1 AstraZeneca PLC Company Information
  51. 6.9.2 AstraZeneca PLC Business Overview
  52. 6.9.3 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio
  54. 6.9.5 AstraZeneca PLC Recent Developments
7 North America
  1. 7.1 North America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst